ClearPoint Neuro, Inc.
CLPTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How ClearPoint Neuro, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 16 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among ClearPoint Neuro, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-17 · BURNETT JOSEPH: Larger than all 15 other insider sales of Common Stock on file. SEC filing
- 2025-06-09 · BURNETT JOSEPH: Larger than 14 of the 15 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-17 | BURNETT JOSEPH · CEO and President | Common Stock | S — Open market or private sale | −1,843 | 17.94 | SEC filing |
| 2026-06-17 | BURNETT JOSEPH · CEO and President | Common Stock | S — Open market or private sale | −60,000 | 17.79 | SEC filing |
| 2026-06-01 | Richards Timothy T. · Director | Common Stock | S — Open market or private sale | −5,415 | 12.17 | SEC filing |
| 2026-05-21 | Klein Matthew B. · Director | Common Stock | S — Open market or private sale | −16,000 | 11.59 | SEC filing |
| 2026-05-20 | FALLON LYNNETTE C · Director | Common Stock | S — Open market or private sale | −5,091 | 11.14 | SEC filing |
| 2026-02-25 | BURNETT JOSEPH · CEO and President | Common Stock | S — Open market or private sale | −19,951 | 15.17 | SEC filing |
| 2026-01-26 | BURNETT JOSEPH · CEO and President | Common Stock | S — Open market or private sale | −2,943 | 15.57 | SEC filing |
| 2026-01-09 | BURNETT JOSEPH · CEO and President | Common Stock | S — Open market or private sale | −20,000 | 16.12 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | BURNETT JOSEPH · CEO and President | Common Stock | M — Exercise or conversion of derivative security | +60,000 | SEC filing |
| 2026-06-17 | BURNETT JOSEPH · CEO and President | Stock Options (right to buy) | M — Exercise or conversion of derivative security | −60,000 | SEC filing |
| 2026-06-04 | Richards Timothy T. · Director | Stock Options (right to buy) | M — Exercise or conversion of derivative security | −500 | SEC filing |
| 2026-06-04 | Richards Timothy T. · Director | Common Stock | M — Exercise or conversion of derivative security | +500 | SEC filing |
| 2026-06-04 | Richards Timothy T. · Director | Common Stock | F — Payment of exercise price or tax by delivering securities | −376 | SEC filing |
| 2026-05-21 | LIAU LINDA M. · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +12,820 | SEC filing |
| 2026-05-21 | FALLON LYNNETTE C · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +12,820 | SEC filing |
| 2026-05-21 | JOHNSON B KRISTINE · Director | Restricted Stock Units | A — Grant, award, or other acquisition | +12,820 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.